guest ::
| Home > Institute Collections > W500 > Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features. |
| Home > Institute Collections > W500 > Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features. |
| Journal Article | DKFZ-2025-02394 |
; ; ; ; ; ; ; ; ;
2020
John Wiley & Sons, Inc.
Hoboken, NJ
Abstract: TP53 gene mutations are very common in human cancer. While such mutations abrogate the tumor suppressive activities of the wild-type (wt) p53 protein, some of them also endow the mutant (mut) protein with oncogenic gain of function (GOF), facilitating cancer progression. Yet, p53 may acquire altered functionality even without being mutated; in particular, experiments with cultured cells revealed that wtp53 can be rewired to adopt mut-like features in response to growth factors or cancer-mimicking genetic manipulations. To assess whether such rewiring also occurs in human tumors, we interrogated gene expression profiles and pathway deregulation patterns in the METABRIC breast cancer (BC) dataset as a function of TP53 gene mutation status. Harnessing the power of machine learning, we optimized a gene expression classifier for ER+Her2- patients that distinguishes tumors carrying TP53 mutations from those retaining wt TP53. Interestingly, a small subset of wt TP53 tumors displayed gene expression and pathway deregulation patterns markedly similar to those of TP53-mutated tumors. Moreover, similar to TP53-mutated tumors, these 'pseudomutant' cases displayed a signature for enhanced proliferation and had worse prognosis than typical wtp53 tumors. Notably, these tumors revealed upregulation of genes which, in BC cell lines, were reported to be positively regulated by p53 GOF mutants. Thus, such tumors may benefit from mut p53-associated activities without having to accrue TP53 mutations.
Keyword(s): Breast Neoplasms: genetics (MeSH) ; Female (MeSH) ; Gene Expression Profiling (MeSH) ; Gene Expression Regulation, Neoplastic (MeSH) ; Humans (MeSH) ; Ki-67 Antigen: metabolism (MeSH) ; Mutant Proteins: genetics (MeSH) ; Mutant Proteins: metabolism (MeSH) ; Mutation: genetics (MeSH) ; Receptor, ErbB-2: metabolism (MeSH) ; Receptors, Estrogen: metabolism (MeSH) ; Tumor Suppressor Protein p53: genetics (MeSH) ; METABRIC ; breast cancer ; machine learning ; p53 gain of function ; pseudomutant p53 ; Ki-67 Antigen ; MKI67 protein, human ; Mutant Proteins ; Receptors, Estrogen ; Tumor Suppressor Protein p53 ; ERBB2 protein, human ; Receptor, ErbB-2
; 
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DEAL Wiley ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
